Amgen (AMGN) EPS Growth is 'Healthy', Target Raised - Jefferies

April 24, 2013 12:24 PM

Amgen (NASDAQ: AMGN) is down over 5 percent Wednesday following Q1 results after the close as investors focus on lower ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found